Nora Dellepiane - Concepedia

Author

Nora Dellepiane

World Health Organization

Also Known As

N Dellepiane, N I Dellepiane, N. Dellepiane, Nora Dellepiane, Nora Ida Dellepiane

Publications

415

Citations

H-Index

Concepts

All Affiliations

World Health Organization Developing Countries Vaccine Manufactures Network

About

Nora Dellepiane is an author at World Health Organization specializing in medicine, vaccination, and vaccinology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	226
2	Public Health	2	2	55
3	Allergy	1	1	47
4	Epidemiology	1	1	44
5	Global Health	1	1	11

Nora Dellepiane

Publications

273

Citations

H-Index

Page 1

	Year	Citations
Guidelines on stability evaluation of vaccines R Dobbelaer, Michael Pfleiderer, Martin Haase, Biologicals VaccinationVaccine SafetyVaccinologyVaccine SurveillanceImmunology	2009	52
New challenges in assuring vaccine quality. Nora Dellepiane, Elwyn Griffiths, Julie B. Milstien PubMed Vaccine RegulationImmunologyInfluenza VaccinesCross-protectionVaccine Surveillance	2000	47
Mass psychogenic illness following tetanus-diphtheria toxoid vaccination in Jordan. S. Kharabsheh, Haidar Al-Otoum, John D. Clements, PubMed VaccinationTetanus-diphtheria Toxoid VaccineYoung PeopleEpidemic IntelligenceDisease Outbreak	2001	44
Challenges for the registration of vaccines in emerging countries: Differences in dossier requirements, application and evaluation processes Nora Dellepiane, Sonia Pagliusi Vaccine	2018	37
WHO Guidelines for the Production and Control of the Acellular Pertussis Component of Monovalent or Combined Vaccines Juan Arciniega, Michael J. Corbel, Nora Dellepiane, Biologicals VaccinationAcellular Pertussis ComponentVaccine DevelopmentMedicineVaccine Surveillance	1998	28
Laboratory testing of whole cell pertussis vaccine: a WHO proficiency study using the Kendrick test D. Xing, Rose Gaines Das, Terence W O’Neill, Vaccine VaccinationVaccinologyLaboratory TestingWho Proficiency StudyVaccine Development	2001	23
Vaccine quality—can a single standard be defined? Julie B. Milstien, Nora Dellepiane, Scott R. Lambert, Vaccine VaccinationVaccine SafetyVaccinologyVaccine SurveillanceVaccine Testing	2002	21
Opportunities for improving access to vaccines in emerging countries through efficient and aligned registration procedures: An industry perspective Nora Dellepiane, Sonia Pagliusi Vaccine Registration ProceduresVaccine HesitancyVaccine StakeholdersVaccine AccessPreventive Medicine	2019	11
Alignment in post-approval changes (PAC) guidelines in emerging countries may increase timely access to vaccines: An illustrative assessment by manufacturers Nora Dellepiane, Sonia Pagliusi, Prashant Akut, Vaccine X	2020	10

Page 1